In SmithKline Beecham Ltd v Remedica Ltd the EU Intellectual Property Office Cancellation Division rejected SmithKline Beecham’s cancellation application based on its earlier EU trademark ELONTRIL against EU trademark CLONOTRIL owned by Remedica.

This legal update is part of World Trademark Review's premium intelligence and is only available to subscribers.

Register to access two of our subscriber only articles per month

Subscribe for unlimited access to articles, in-depth analysis and research from the World Trademark Review experts

Already registered? Log in

What our customers are saying

"World Trademark Report is the best service of its type. No other service reports international case law and law changes faster and more concisely. Keep up the good work."

Mary M. Squyres
Brinks Gilson & Lione Chicago, Illinois USA

Benefits

Subscribe to World Trademark Review to receive access to the full range of trademark intelligence, insight, and case law, as well as our guides, rankings and daily market insight delivered to your inbox.

Why subscribe?

Share this article